1. Home
  2. IPSC vs BCIC Comparison

IPSC vs BCIC Comparison

Compare IPSC & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.33

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

BCIC

BCP Investment Corporation

N/A

Current Price

$11.45

Market Cap

162.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IPSC
BCIC
Founded
2019
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
162.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPSC
BCIC
Price
$2.33
$11.45
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
976.3K
54.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
16.39%
EPS Growth
29.07
N/A
EPS
0.11
N/A
Revenue
$6,589,000.00
N/A
Revenue This Year
$1,590.09
N/A
Revenue Next Year
N/A
$14.87
P/E Ratio
$20.64
$7.27
Revenue Growth
194.81
N/A
52 Week Low
$0.34
$11.13
52 Week High
$2.71
$13.50

Technical Indicators

Market Signals
Indicator
IPSC
BCIC
Relative Strength Index (RSI) 62.07 35.58
Support Level $0.49 $11.13
Resistance Level $2.71 $12.43
Average True Range (ATR) 0.19 0.27
MACD 0.02 -0.06
Stochastic Oscillator 79.33 14.41

Price Performance

Historical Comparison
IPSC
BCIC

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About BCIC BCP Investment Corporation

BCP Investment Corp is a closed-end, externally managed, non-diversified management investment company. The company invests in performing, well- established middle market businesses that operate across a wide range of industries. It employs fundamental credit analysis, targeting investments in businesses with relatively low levels of cyclicality and operating risk.

Share on Social Networks: